tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DYN Stock Latest News

Dyne Therapeutics participates in a conference call with JPMorgan
The FlyDyne Therapeutics participates in a conference call with JPMorgan
10d ago
DYN
ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz
PremiumThe Fly
ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz
17d ago
H
T
Oppenheimer says Dyne Therapeutics weakness on management changes ‘overblown’
PremiumThe Fly
Oppenheimer says Dyne Therapeutics weakness on management changes ‘overblown’
17d ago
DYN
Stifel views pullback in Dyne Therapeutics shares as buying opportunity
PremiumThe Fly
Stifel views pullback in Dyne Therapeutics shares as buying opportunity
17d ago
DYN
Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon
PremiumThe Fly
Morning Movers: U.S. Steel drops after VP Harris opposes sale to Nippon
17d ago
U
X
Dyne Therapeutics: Executive Shifts and Promising Clinical Trials
PremiumCompany AnnouncementsDyne Therapeutics: Executive Shifts and Promising Clinical Trials
17d ago
8K
DYN
Dyne Therapeutics’ DYNE-251 in DMD shows efficacy in Phase 1/2 trial
Premium
The Fly
Dyne Therapeutics’ DYNE-251 in DMD shows efficacy in Phase 1/2 trial
17d ago
DYN
Dyne Therapeutics announces leadership announcements
Premium
The Fly
Dyne Therapeutics announces leadership announcements
17d ago
DYN
Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts
PremiumPress Releases
Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts
17d ago
DYN
Dyne Therapeutics Announces Key Leadership Appointments
PremiumPress Releases
Dyne Therapeutics Announces Key Leadership Appointments
17d ago
DYN
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
PremiumPress Releases
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
22d ago
DYN
Dyne Therapeutics price target raised to $66 from $41 at Stifel
PremiumThe Fly
Dyne Therapeutics price target raised to $66 from $41 at Stifel
1M ago
DYN
Dyne Therapeutics price target raised to $52 from $48 at Morgan Stanley
PremiumThe FlyDyne Therapeutics price target raised to $52 from $48 at Morgan Stanley
1M ago
DYN
Dyne Therapeutics price target raised to $53 from $43 at Piper Sandler
Premium
The Fly
Dyne Therapeutics price target raised to $53 from $43 at Piper Sandler
1M ago
DYN
Dyne Therapeutics price target raised to $55 from $48 at H.C. Wainwright
Premium
The Fly
Dyne Therapeutics price target raised to $55 from $48 at H.C. Wainwright
1M ago
DYN
Dyne Therapeutics price target raised to $50 from $42 at Chardan
PremiumThe Fly
Dyne Therapeutics price target raised to $50 from $42 at Chardan
1M ago
DYN
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
PremiumPress Releases
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
1M ago
DYN
Dyne Therapeutics reports Q2 EPS (70c), consensus (72c)
PremiumThe Fly
Dyne Therapeutics reports Q2 EPS (70c), consensus (72c)
1M ago
DYN
Dyne Therapeutics price target raised to $43 from $39 at JPMorgan
PremiumThe Fly
Dyne Therapeutics price target raised to $43 from $39 at JPMorgan
2M ago
DYN
Dyne Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyDyne Therapeutics participates in a conference call with JPMorgan
3M ago
DYN
Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease
Premium
Press Releases
Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease
3M ago
DYN
Dyne announces new Pompe disease data showing potential of FORCE platform
Premium
The Fly
Dyne announces new Pompe disease data showing potential of FORCE platform
3M ago
DYN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >